A citation-based method for searching scientific literature

Huanhuan Jin, Naqi Lian, Mianli Bian, Chenxi Zhang, Xingran Chen, Jiangjuan Shao, Li Wu, Anping Chen, Qinglong Guo, Feng Zhang, Shizhong Zheng. Cell Prolif 2018
Times Cited: 21







List of co-cited articles
95 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


YAP/TEAD-mediated transcription controls cellular senescence.
Qi Xie, Jing Chen, Han Feng, Shengyi Peng, Ursula Adams, Yujie Bai, Li Huang, Ji Li, Junjian Huang, Songshu Meng,[...]. Cancer Res 2013
83
33

Cellular senescence drives age-dependent hepatic steatosis.
Mikolaj Ogrodnik, Satomi Miwa, Tamar Tchkonia, Dina Tiniakos, Caroline L Wilson, Albert Lahat, Christoper P Day, Alastair Burt, Allyson Palmer, Quentin M Anstee,[...]. Nat Commun 2017
295
23

Alcoholic liver disease: mechanisms of injury and targeted treatment.
Alexandre Louvet, Philippe Mathurin. Nat Rev Gastroenterol Hepatol 2015
333
23

The Hippo pathway effector YAP controls mouse hepatic stellate cell activation.
Inge Mannaerts, Sofia Batista Leite, Stefaan Verhulst, Sofie Claerhout, Nathalie Eysackers, Lien F R Thoen, Anne Hoorens, Hendrik Reynaert, Georg Halder, Leo A van Grunsven. J Hepatol 2015
155
19

Oroxylin A prevents alcohol-induced hepatic steatosis through inhibition of hypoxia inducible factor 1alpha.
Huanhuan Jin, Naqi Lian, Mianli Bian, Chenxi Zhang, Xingran Chen, Jiangjuan Shao, Li Wu, Anping Chen, Qinglong Guo, Feng Zhang,[...]. Chem Biol Interact 2018
12
33

Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration.
James L Grijalva, Megan Huizenga, Kaly Mueller, Steven Rodriguez, Joseph Brazzo, Fernando Camargo, Ghazaleh Sadri-Vakili, Khashayar Vakili. Am J Physiol Gastrointest Liver Physiol 2014
88
14

TEAD mediates YAP-dependent gene induction and growth control.
Bin Zhao, Xin Ye, Jindan Yu, Li Li, Weiquan Li, Siming Li, Jianjun Yu, Jiandie D Lin, Cun-Yu Wang, Arul M Chinnaiyan,[...]. Genes Dev 2008
14

Oroxylin A inhibits H2O2-induced oxidative stress in PC12 cells.
Qinghe Han, Haiyu Wang, Chong Xiao, Ben-Dong Fu, Chong-Tao Du. Nat Prod Res 2017
10
30

Reversal of human cellular senescence: roles of the p53 and p16 pathways.
Christian M Beauséjour, Ana Krtolica, Francesco Galimi, Masashi Narita, Scott W Lowe, Paul Yaswen, Judith Campisi. EMBO J 2003
827
14

Emerging evidence on the role of the Hippo/YAP pathway in liver physiology and cancer.
Dean Yimlamai, Brendan H Fowl, Fernando D Camargo. J Hepatol 2015
110
14

Elucidation of a universal size-control mechanism in Drosophila and mammals.
Jixin Dong, Georg Feldmann, Jianbin Huang, Shian Wu, Nailing Zhang, Sarah A Comerford, Mariana F Gayyed, Robert A Anders, Anirban Maitra, Duojia Pan. Cell 2007
14

Activation of autophagy is required for Oroxylin A to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation.
Weiwei Chen, Zili Zhang, Zhen Yao, Ling Wang, Feng Zhang, Jiangjuan Shao, Anping Chen, Shizhong Zheng. Int Immunopharmacol 2018
33
14

Oroxylin A prevents angiogenesis of LSECs in liver fibrosis via inhibition of YAP/HIF-1α signaling.
Chenxi Zhang, Mianli Bian, Xingran Chen, Huanhuan Jin, Shifeng Zhao, Xiang Yang, Jiangjuan Shao, Anping Chen, Qinglong Guo, Feng Zhang,[...]. J Cell Biochem 2018
20
15

Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues.
Virginia Hernández-Gea, Zahra Ghiassi-Nejad, Raphael Rozenfeld, Ronald Gordon, Maria Isabel Fiel, Zhenyu Yue, Mark J Czaja, Scott L Friedman. Gastroenterology 2012
350
14

Alcoholic liver disease.
Helmut K Seitz, Ramon Bataller, Helena Cortez-Pinto, Bin Gao, Antoni Gual, Carolin Lackner, Philippe Mathurin, Sebastian Mueller, Gyongyi Szabo, Hidekazu Tsukamoto. Nat Rev Dis Primers 2018
191
14

Up-regulation of FOXD1 by YAP alleviates senescence and osteoarthritis.
Lina Fu, Yuqiong Hu, Moshi Song, Zunpeng Liu, Weiqi Zhang, Fa-Xing Yu, Jun Wu, Si Wang, Juan Carlos Izpisua Belmonte, Piu Chan,[...]. PLoS Biol 2019
32
14

Dihydroartemisinin protects against alcoholic liver injury through alleviating hepatocyte steatosis in a farnesoid X receptor-dependent manner.
Wenxuan Xu, Chunfeng Lu, Lu Yao, Feng Zhang, Jiangjuan Shao, Shizhong Zheng. Toxicol Appl Pharmacol 2017
20
10

Senescence induced by altered telomere state, not telomere loss.
Jan Karlseder, Agata Smogorzewska, Titia de Lange. Science 2002
587
9

Role of telomere dysfunction in aging and its detection by biomarkers.
Guido von Figura, Daniel Hartmann, Zhangfa Song, Karl Lenhard Rudolph. J Mol Med (Berl) 2009
45
9


Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans.
Charalambos Gustav Antoniades, Alberto Quaglia, Leonie S Taams, Ragai R Mitry, Munther Hussain, Robin Abeles, Lucia A Possamai, Matthew Bruce, Mark McPhail, Christopher Starling,[...]. Hepatology 2012
159
9

Oroxylin A induced apoptosis of human hepatocellular carcinoma cell line HepG2 was involved in its antitumor activity.
Yang Hu, Yong Yang, Qi-Dong You, Wei Liu, Hong-Yan Gu, Li Zhao, Kun Zhang, Wei Wang, Xiao-Tang Wang, Qing-Long Guo. Biochem Biophys Res Commun 2006
59
9

Beclin 1-mediated autophagy in hepatocellular carcinoma cells: implication in anticancer efficiency of oroxylin A via inhibition of mTOR signaling.
Meijuan Zou, Na Lu, Chen Hu, Wei Liu, Yajing Sun, Xiaotang Wang, Qidong You, Cong Gu, Tao Xi, Qinglong Guo. Cell Signal 2012
58
9

Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.
Michelle M Richardson, Julie R Jonsson, Elizabeth E Powell, Elizabeth M Brunt, Brent A Neuschwander-Tetri, Prithi S Bhathal, John B Dixon, Martin D Weltman, Herbert Tilg, Alexander R Moschen,[...]. Gastroenterology 2007
305
9

Telomere shortening in the damaged small bile ducts in primary biliary cirrhosis reflects ongoing cellular senescence.
Motoko Sasaki, Hiroko Ikeda, Junpei Yamaguchi, Satoko Nakada, Yasuni Nakanuma. Hepatology 2008
76
9

The essence of senescence.
Thomas Kuilman, Chrysiis Michaloglou, Wolter J Mooi, Daniel S Peeper. Genes Dev 2010
9

Nrf2 Activation Is Required for Ligustrazine to Inhibit Hepatic Steatosis in Alcohol-Preferring Mice and Hepatocytes.
Chunfeng Lu, Wenxuan Xu, Jiangjuan Shao, Feng Zhang, Anping Chen, Shizhong Zheng. Toxicol Sci 2017
18
11

Premature telomere shortening and impaired regenerative response in hepatocytes of individuals with NAFLD.
Tomoki Nakajima, Michihisa Moriguchi, Tatsuo Katagishi, Satoru Sekoguchi, Taichirou Nishikawa, Hidetaka Takashima, Hiroyuki Kimura, Masahito Minami, Yoshito Itoh, Keizo Kagawa,[...]. Liver Int 2006
49
9

Oroxylin A accelerates liver regeneration in CCl₄-induced acute liver injury mice.
Runzhi Zhu, Guofang Zeng, Yinqin Chen, Qingyu Zhang, Bin Liu, Jie Liu, Hege Chen, Mingyi Li. PLoS One 2013
14
14

Nrf2 Knockdown Disrupts the Protective Effect of Curcumin on Alcohol-Induced Hepatocyte Necroptosis.
Chunfeng Lu, Wenxuan Xu, Feng Zhang, Jiangjuan Shao, Shizhong Zheng. Mol Pharm 2016
43
9

Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells.
Feng Zhang, Zili Zhang, Li Chen, Desong Kong, Xiaoping Zhang, Chunfeng Lu, Yin Lu, Shizhong Zheng. J Cell Mol Med 2014
82
9

Senescence of activated stellate cells: not just early retirement.
Jörg Schrader, Jonathan Fallowfield, John P Iredale. Hepatology 2009
13
15

Oroxylin A attenuates cigarette smoke-induced lung inflammation by activating Nrf2.
Jihe Li, Dongxia Tong, Juan Liu, Fuyang Chen, Yongbin Shen. Int Immunopharmacol 2016
21
9


Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease.
Mariana Verdelho Machado, Gregory Alexander Michelotti, Thiago Almeida Pereira, Guanhua Xie, Richard Premont, Helena Cortez-Pinto, Anna Mae Diehl. J Hepatol 2015
60
9

Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver.
Li Lu, Ying Li, Soo Mi Kim, Wouter Bossuyt, Pu Liu, Qiong Qiu, Yingdi Wang, Georg Halder, Milton J Finegold, Ju-Seog Lee,[...]. Proc Natl Acad Sci U S A 2010
502
9

Ligand Activation of PPARγ by Ligustrazine Suppresses Pericyte Functions of Hepatic Stellate Cells via SMRT-Mediated Transrepression of HIF-1α.
Feng Zhang, Shuai Lu, Jianlin He, Huanhuan Jin, Feixia Wang, Li Wu, Jiangjuan Shao, Anping Chen, Shizhong Zheng. Theranostics 2018
33
9

The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies.
Luping Lin, Amit J Sabnis, Elton Chan, Victor Olivas, Lindsay Cade, Evangelos Pazarentzos, Saurabh Asthana, Dana Neel, Jenny Jiacheng Yan, Xinyuan Lu,[...]. Nat Genet 2015
281
9

The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1.
Carsten Gram Hansen, Yuen Lam Dora Ng, Wai-Ling Macrina Lam, Steven W Plouffe, Kun-Liang Guan. Cell Res 2015
99
9

Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma.
Weiying Zhang, Nivedita Nandakumar, Yuhao Shi, Mark Manzano, Alias Smith, Garrett Graham, Swati Gupta, Eveline E Vietsch, Sean Z Laughlin, Mandheer Wadhwa,[...]. Sci Signal 2014
207
9

Metformin mediates resensitivity to 5-fluorouracil in hepatocellular carcinoma via the suppression of YAP.
Yu Tian, Bo Tang, Chengye Wang, Deguang Sun, Rixin Zhang, Nan Luo, Zhao Han, Rui Liang, Zhenming Gao, Liming Wang. Oncotarget 2016
25
9

Metformin inhibits glioma cells stemness and epithelial-mesenchymal transition via regulating YAP activity.
Xuesong Yuan, Wenfeng Wei, Qing Bao, Hongchun Chen, Peng Jin, Wenqing Jiang. Biomed Pharmacother 2018
17
11

dNTP metabolism links mechanical cues and YAP/TAZ to cell growth and oncogene-induced senescence.
Giulia Santinon, Irene Brian, Arianna Pocaterra, Patrizia Romani, Elisa Franzolin, Chiara Rampazzo, Silvio Bicciato, Sirio Dupont. EMBO J 2018
33
9

Effect of epigallocatechin-3-gallate on iron overload in mice with alcoholic liver disease.
Yuan Ren, Fengjun Deng, Hang Zhu, Weiren Wan, Jufeng Ye, Bingde Luo. Mol Biol Rep 2011
20
10

Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases.
Shashi Bala, Jan Petrasek, Shiv Mundkur, Donna Catalano, Ivan Levin, Jeanine Ward, Hawau Alao, Karen Kodys, Gyongyi Szabo. Hepatology 2012
413
9

UPLC/Q-TOFMS-Based Metabolomics Studies on the Protective Effect of Panax notoginseng Saponins on Alcoholic Liver Injury.
Fang Liu, Xu Bai, Ren-Bo Ding, Yuan-Jia Hu, Huanxing Su, Jian-Bo Wan. Am J Chin Med 2015
21
9

Wogonin attenuates inflammation by activating PPAR-γ in alcoholic liver disease.
Hai-Di Li, Xin Chen, Yang Yang, Hui-Min Huang, Ling Zhang, Xin Zhang, Lei Zhang, Cheng Huang, Xiao-Ming Meng, Jun Li. Int Immunopharmacol 2017
34
9

Naringin attenuates alcoholic liver injury by reducing lipid accumulation and oxidative stress.
Chuying Zhou, Yuling Lai, Peng Huang, Lingpeng Xie, Haiyan Lin, Zhenting Zhou, Chan Mo, Guanghui Deng, Weixin Yan, Zhuowei Gao,[...]. Life Sci 2019
25
9

Oxidative stress and alcoholic liver disease.
Defeng Wu, Arthur I Cederbaum. Semin Liver Dis 2009
188
9

Trends in the management and burden of alcoholic liver disease.
Philippe Mathurin, Ramon Bataller. J Hepatol 2015
145
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.